Monkeypox Virus Is Inhibited by Nucleoside Analogues Including the Acyclic Phosphonates Adefovir and Tenofovir In Vitro
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Jasper Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Center for ViroScience and Cure, Atlanta, Geor…. Hauptthemen laut MEDLINE: Antiviral Agents, Organophosphonates, Adenine, Monkeypox virus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: S.G.S. acknowledges funding from the Nahmias-Schinazi Distinguished Chair in Research, NIH research grant R37AI076119, and from the Imagine, Innovate, and Impa….
Abstract (Originalsprache)
Mpox, caused by the orthopoxvirus monkeypox virus (MPXV), has garnered worldwide attention during a global outbreak in 2022 and in an ongoing outbreak in Central Africa. Because of drug resistance and toxicity risks with current antiviral treatments, there is still a need for additional antivirals to treat mpox and other orthopoxvirus diseases. We developed in vitro screening assays using recombinant strains of vaccinia virus and MPXV to measure the antiviral potency of compounds, finding that adefovir dipivoxil and tenofovir alafenamide had potent anti‐orthopoxvirus activity and low toxicity. These data reinforce interest in repurposing nucleoside analogues as antivirals to treat poxvirus infections and provide a basis for high throughput screening and mechanistic and antiviral resistance studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Center for ViroScience and Cure, Atlanta, Georgia, USA.
- Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Poxvirus and Rabies Branch, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Division of High-Consequence Pathogens and Pathology, Atlanta, Georgia, USA.
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Emory University School of Medicine, Emory Chemical Biology Discovery Center, Atlanta, Georgia, USA.
- Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Stefan G Sarafianos
Förderung
- S.G.S. acknowledges funding from the Nahmias-Schinazi Distinguished Chair in Research, NIH research grant R37AI076119, and from the Imagine, Innovate, and Impa…
Zitieren
APA
Lee, J., Zhang, H., Boggs, E. A., Kilcullen, J., Moriarty, M., Du, Y., Fu, H., Lan, S., Hutson, C. L., Satheshkumar, P. S., Tedbury, P. R., & Sarafianos, S. G. (2025). Monkeypox Virus Is Inhibited by Nucleoside Analogues Including the Acyclic Phosphonates Adefovir and Tenofovir In Vitro. Journal of Medical Virology. https://doi.org/10.1002/jmv.70669
Vancouver
Lee J, Zhang H, Boggs EA, Kilcullen J, Moriarty M, Du Y, et al. Monkeypox Virus Is Inhibited by Nucleoside Analogues Including the Acyclic Phosphonates Adefovir and Tenofovir In Vitro. Journal of Medical Virology. 2025. doi:10.1002/jmv.70669
BibTeX
@article{Lee2025,
author = {Lee, Jasper and Zhang, Huanchun and Boggs, Emerson Ailidh and Kilcullen, Jesse and Moriarty, Margaret and Du, Yuhong and Fu, Haian and Lan, Shuiyun and Hutson, Christina L and Satheshkumar, Panayampalli S and Tedbury, Philip R and Sarafianos, Stefan G},
title = {Monkeypox Virus Is Inhibited by Nucleoside Analogues Including the Acyclic Phosphonates Adefovir and Tenofovir In Vitro},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70669}
}
EUVIMED